Are Options Traders Bullish on ANAB?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ANAB

AnaptysBio is a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation. The companys proprietary anti-inflammatory pipeline includes its anti-IL-33 antibody (ANB020) for the treatment of moderate-to-severe adult atopic dermatitis, severe adult peanut allergy and severe adult eosinophilic asthma; its anti-IL-36R antibody (ANB019) for the treatment of rare inflammatory diseases, including generalized pustular psoriasis and palmo-plantar pustular psoriasis; and a portfolio of checkpoint receptor agonist antibodies for the treatment of certain autoimmune diseases where immune checkpoint receptors are insufficiently activated and have demonstrated efficacy in an animal model of graft-versus-host disease. AnaptysBios antibody pipeline has been developed using its proprietary somatic hypermutation (SHM) platform, which uses in vitro SHM for antibody discovery and is designed to replicate key features of the human immune system to overcome the limitations of competing antibody discovery technologies. AnaptysBio has also developed multiple therapeutic antibodies in an immuno-oncology partnership with TESARO and an inflammation partnership with Celgene, including an anti-PD-1 antagonist antibody (TSR-042) and an anti-TIM-3 antagonist antibody (TSR-022), which are currently under clinical development with TESARO, and an anti-PD-1 checkpoint agonist antibody (CC-90006) currently in the clinic with Celgene.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ANAB is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 306.2 M 3.06159E+08 202 202 0.1% 0.00104346 667 K 667241
DWAQ Invesco DWA NASDAQ Momentum ETF 43.3 M 4.33E+07 100 100 0.68% 0.00682 308 K 307836
DWAS Invesco DWA SmallCap Momentum ETF 341.0 M 3.41E+08 200 200 0.43% 0.00432 1.5 M 1530720
EQWS Invesco Russell 2000 Equal Weight ETF 21.1 M 2.11E+07 1,981 1981 0.03% 0.00027 6 K 5714
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 348 348 0.03% 0.00028661 461 K 460814
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.19583E+09 191 191 0.24% 0.0024 20.1 M 2.01234E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.5 B 1.54647E+10 3,424 3424 0.01% 0.0001 909 K 908682
IWM iShares Russell 2000 ETF 44.0 B 4.40384E+10 2,026 2026 0.07% 0.0007 29.8 M 2.97711E+07
IWO iShares Russell 2000 Growth ETF 9.2 B 9.22834E+09 1,243 1243 0.13% 0.0013 12.5 M 1.24717E+07
IWV iShares Russell 3000 ETF 8.4 B 8.38468E+09 3,009 3009 0.0% 0 385 K 385230
JKJ iShares Morningstar Small-Cap ETF 233.8 M 2.33802E+08 258 258 0.27% 0.0027 637 K 636504
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 1,029 1029 0.02% 0.000174987 330 K 330476
SBIO ALPS Medical Breakthroughs ETF 228.7 M 2.28652E+08 112 112 1.24% 0.0124 2.8 M 2835285
UBIO Proshares UltraPro Nasdaq Biotechnology 30.3 M 3.03348E+07 196 196 0.05% 0.000478215 48 K 48361
URTY ProShares UltraPro Russell2000 113.9 M 1.1394E+08 2,036 2036 0.01% 0.000117855 46 K 45608
UWM ProShares Ultra Russell2000 187.9 M 1.8788E+08 2,036 2036 0.03% 0.000293488 115 K 114725
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.6 B 4.59589E+09 126 126 1.19% 0.0118882 53.4 M 5.342344E+07
FAD First Trust Multi Cap Growth AlphaDEX Fund 197.2 M 1.97196E+08 675 675 0.04% 0.0004 79 K 78878
FYC First Trust Small Cap Growth AlphaDEX Fund 413.6 M 4.13586E+08 262 262 0.21% 0.0021 869 K 868531
FYX First Trust Small Cap Core AlphaDEX Fund 673.4 M 6.73351E+08 526 526 0.05% 0.0005 337 K 336675

Wait, Before You Leave...